Abstract
The acquisition of invasiveness in ovarian cancer (OC) is accompanied by the process of epithelial-to-mesenchymal transition (EMT). The MUC4 mucin is overexpressed in ovarian tumors and has a role in the invasiveness of OC cells. The present study was aimed at evaluating the potential involvement of MUC4 in the metastasis of OC cells by inducing EMT. Ectopic overexpression of MUC4 in OC cells (SKOV3-MUC4) resulted in morphological alterations along with a decreased expression of epithelial markers (E-cadherin and cytokeratin (CK)-18) and an increased expression of mesenchymal markers (N-cadherin and vimentin) compared with the control cells (SKOV3-vector). Also, pro-EMT transcription factors TWIST1, TWIST2 and SNAIL showed an upregulation in SKOV3-MUC4 cells. We further investigated the pathways upstream of N-cadherin, such as focal adhesion kinase (FAK), MKK7, JNK1/2 and c-Jun, which were also activated in the SKOV3-MUC4 cells compared with SKOV3-vector cells. Inhibition of phospho-FAK (pFAK) and pJNK1/2 decreased N-cadherin expression in the MUC4-overexpressing cells, which further led to a significant decrease in cellular motility. Knockdown of N-cadherin decreased the activation of extracellular signal-regulated kinase-1/2 (ERK1/2), AKT and matrix metalloproteinase 9 (MMP9), and inhibited the motility in the SKOV3-MUC4 cells. Upon in vivo tumorigenesis and metastasis analysis, the SKOV3-MUC4 cells produced significantly larger tumors and demonstrated a higher incidence of metastasis to distance organs (peritoneal wall, colon, intestine, stomach, lymph nodes, liver and diaphragm). Taken together, our study reveals a novel role for MUC4 in inducing EMT through the upregulation of N-cadherin and promoting metastasis of OC cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
Purchase on Springer Link
Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- EGF:
-
epidermal growth factor
- EGFR:
-
epidermal growth factor receptor
- FAK:
-
focal adhesion kinase
- FBS:
-
fetal bovine serum
- SMC:
-
sialo mucin complex
References
Ahmed N, Thompson EW, Quinn MA . (2007). Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 213: 581–588.
Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA et al. (2001). Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 7: 4033–4040.
Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S et al. (1999). E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA 96: 6249–6254.
Behrens J . (1994). Cadherins as determinants of tissue morphology and suppressors of invasion. Acta Anat (Basel) 149: 165–169.
Boman F, Buisine MP, Wacrenier A, Querleu D, Aubert JP, Porchet N . (2001). Mucin gene transcripts in benign and borderline mucinous tumours of the ovary: an in situ hybridization study. J Pathol 193: 339–344.
Carraway KL, Price-Schiavi SA, Komatsu M, Jepson S, Perez A, Carraway CA . (2001). Muc4/sialomucin complex in the mammary gland and breast cancer. J Mammary Gland Biol Neoplasia 6: 323–337.
Chaturvedi P, Singh AP, Moniaux N, Senapati S, Chakraborty S, Meza JL et al. (2007). MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Mol Cancer Res 5: 309–320.
Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, Smith LM et al. (2006). Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol 19: 1386–1394.
Chen H, Paradies NE, Fedor-Chaiken M, Brackenbury R . (1997). E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J Cell Sci 110: 345–356.
Cunningham CC, Gorlin JB, Kwiatkowski DJ, Hartwig JH, Janmey PA, Byers HR et al. (1992). Actin-binding protein requirement for cortical stability and efficient locomotion. Science 255: 325–327.
Fidler IJ . (1990). Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 50: 6130–6138.
Folkman J . (1990). Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction. Cancer Metastasis Rev 9: 171–174.
Giuntoli RL, Rodriguez GC, Whitaker RS, Dodge R, Voynow JA . (1998). Mucin gene expression in ovarian cancers. Cancer Res 58: 5546–5550.
Golubovskaya VM, Nyberg C, Zheng M, Kweh F, Magis A, Ostrov D et al. (2008). A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. J Med Chem 51: 7405–7416.
Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA . (2007). A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13: 7003–7011.
Hazan RB, Kang L, Whooley BP, Borgen PI . (1997). N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4: 399–411.
Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA . (2000). Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148: 779–790.
Hazan RB, Qiao R, Keren R, Badano I, Suyama K . (2004). Cadherin switch in tumor progression. Ann NY Acad Sci 1014: 155–163.
Hollingsworth MA, Swanson BJ . (2004). Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4: 45–60.
Horn G, Gaziel A, Wreschner DH, Smorodinsky NI, Ehrlich M . (2009). ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1. Exp Cell Res 315: 1490–1504.
Kang Y, Massague J . (2004). Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118: 277–279.
Kolosionek E, Savai R, Ghofrani HA, Weissmann N, Guenther A, Grimminger F et al. (2009). Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4. Mol Biol Cell 20: 4751–4765.
Kondo K, Kohno N, Yokoyama A, Hiwada K . (1998). Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res 58: 2014–2019.
Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y . (2009). Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15: 195–206.
Lopez-Ferrer A, Alameda F, Barranco C, Garrido M, de Bolós C . (2001). MUC4 expression is increased in dysplastic cervical disorders. Hum Pathol 32: 1197–1202.
Maeda M, Johnson KR, Wheelock MJ . (2005). Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 118: 873–887.
Moniaux N, Chaturvedi P, Varshney GC, Meza JL, Rodriguez-Sierra JF, Aubert JP et al. (2007). Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells. Br J Cancer 97: 345–357.
Moniaux N, Nollet S, Porchet N, Degand P, Laine A, Aubert JP . (1999). Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J 338: 325–333.
Moniaux N, Varshney GC, Chauhan SC, Copin MC, Jain M, Wittel UA et al. (2004). Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans. J Histochem Cytochem 52: 253–261.
Nollet S, Moniaux N, Maury J, Petitprez D, Degand P, Laine A et al. (1998). Human mucin gene MUC4: organization of its 5′-region and polymorphism of its central tandem repeat array. Biochem J 332: 739–748.
Ponnusamy MP, Singh AP, Jain M, Chakraborty S, Moniaux N, Batra SK . (2008). MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. Br J Cancer 99: 520–526.
Shintani Y, Fukumoto Y, Chaika N, Svoboda R, Wheelock MJ, Johnson KR . (2008). Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol 180: 1277–1289.
Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK . (2004). Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res 64: 622–630.
Sommers CL . (1996). The role of cadherin-mediated adhesion in breast cancer. J Mammary Gland Biol Neoplasia 1: 219–229.
Suyama K, Shapiro I, Guttman M, Hazan RB . (2002). A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2: 301–314.
Theriault BL, Shepherd TG, Mujoomdar ML, Nachtigal MW . (2007). BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis 28: 1153–1162.
Thiery JP . (2002). Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442–454.
Truant S, Bruyneel E, Gouyer V, De WO, Pruvot FR, Mareel M et al. (2003). Requirement of both mucins and proteoglycans in cell-cell dissociation and invasiveness of colon carcinoma HT-29 cells. Int J Cancer 104: 683–694.
Acknowledgements
This work are supported by the grants from the National Institutes of Health (CA78590, CA111294, CA127297, CA133774 and CA131944), Department of Defense (BC074639) and the Susan G Komen Foundation (KG070826). We thank Ms Kristi L Berger for editing the paper. The authors acknowledge the invaluable technical support from Mr Erik Moore and Mrs Kavita Mallya. We also thank Janice A Tayor and James R Talaska of the confocal laser scanning microscope core facility at the UNMC for their support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Ponnusamy, M., Lakshmanan, I., Jain, M. et al. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 29, 5741–5754 (2010). https://doi.org/10.1038/onc.2010.309
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.309
Keywords
This article is cited by
-
PRDM16 functions as a suppressor of lung adenocarcinoma metastasis
Journal of Experimental & Clinical Cancer Research (2019)
-
Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer
Oncogene (2018)
-
Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity
Oncogene (2017)
-
Epithelial–mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways
Oncogene (2017)
-
The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer
Journal of Experimental & Clinical Cancer Research (2016)